Anticonvulsants for Neuropathic Pain Market – Highlights on Trends & Need 2025
Carbamazepine, the world’s first anticonvulsant examined in clinical trials, continues to remain one of the key choices of healthcare practitioners for neuropathic pain conditions.
View full press release